A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 )

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to measure the safety and efficacy of LY4152199 in participants with previously treated B-cell lymphoma and leukemia. This study has two parts. In the first part, the study will find the best dose of the drug. In the second part, the study will see how well the best dose works in participants with certain types of B-cell cancer and leukemia.
Epistemonikos ID: 55f2b22d6596bef3e96d77b7384e6ca6cc45a529
First added on: Aug 05, 2025